本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xtl生物製藥

2.66
-0.1200-4.32%
成交量:974
成交額:2,627.79
市值:653.70萬
市盈率:-0.85
高:2.66
開:2.66
低:2.66
收:2.78
52周最高:10.28
52周最低:2.01
股本:245.75萬
流通股本:138.37萬
量比:0.06
換手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-3.1316
每股收益(LYR):-5.9716
淨資產收益率:-29.30%
總資產收益率:-21.01%
市淨率:-25.74
市盈率(LYR):-0.45

資料載入中...

2026/06/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/05/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/19

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/11/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]